The debate between CAR T-cell therapy and bispecific antibodies is not a rivalry but a question of sequencing, ...

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...

(Reuters) -Drugmaker Eli Lilly is in advanced talks to acquire gene-editing startup Verve Therapeutics for up to $1.3 billion ...

This was the ADR's third consecutive day of losses.

AstraZeneca PLC closed 20.36% short of its 52-week high of £133.88, which the company achieved on September 3rd.

US chemical output slows, National Resilience consolidates operations, AstraZeneca partners with a Chinese firm, and more ...

SHANGHAI (Reuters) -Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing ...

AstraZeneca PLC has acquired a significant stake of 15.86% in Niox Group PLC, according to a recent company filing. This move ...

Astrazeneca (AZN) closed the most recent trading day at $73.55, moving -1.17% from the previous trading session. The stock's ...

NodThera Announces Appointment of Elisabeth Björk as Board Member Former SVP at AstraZeneca R&D brings deep expertise in ...

Head Ali El-Ghamrawy has met with AstraZeneca Egypt Country President Hatem El-Werdany to discuss ways to boost collaboration ...

The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, ...